Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C

The Korean journal of hepatology

Volumn 14, Issue 1, 2008, Pages 36-45

  Kim, Kyoung Tae ^a   Han, Sang Young ^a   Kim, Jong Han ^a   Yoon, Hyun Ah ^a   Baek, Yang Hyun ^a   Kim, Min Ji ^a   Lee, Sung Wook ^a   Jang, Jin Seok ^a   Lee, Jong Hun ^a   Roh, Myung Hwan ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALPHA2A; RIBAVIRIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG COMBINATION; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; TREATMENT OUTCOME;

EID: 58149119720     PISSN: 1738222X     EISSN: None     Source Type: Journal    
DOI: 10.3350/kjhep.2008.14.1.36     Document Type: Article

References (0)